View in EDS PDF Full Text

Cellular and humoral immune responses and breakthrough infections after three SARS-CoV-2 mRNA vaccine doses.

Saved in:
Bibliographic Details
Title: Cellular and humoral immune responses and breakthrough infections after three SARS-CoV-2 mRNA vaccine doses.
Authors: Almendro-Vázquez P; Instituto de Investigación Sanitaria Hospital 12 de Octubre (imas12), Madrid, Spain., Chivite-Lacaba M; Instituto de Investigación Sanitaria Hospital 12 de Octubre (imas12), Madrid, Spain., Utrero-Rico A; Instituto de Investigación Sanitaria Hospital 12 de Octubre (imas12), Madrid, Spain., González-Cuadrado C; Instituto de Investigación Sanitaria Hospital 12 de Octubre (imas12), Madrid, Spain., Laguna-Goya R; Instituto de Investigación Sanitaria Hospital 12 de Octubre (imas12), Madrid, Spain.; Department of Immunology, Hospital Universitario 12 de Octubre, Madrid, Spain.; Centro de Investigación Biomédica en Red (CIBER) de Enfermedades Infecciosas (CIBERINFEC - Instituto de Salud Carlos III), Madrid, Spain., Moreno-Batanero M; Instituto de Investigación Sanitaria Hospital 12 de Octubre (imas12), Madrid, Spain., Sánchez-Paz L; Instituto de Investigación Sanitaria Hospital 12 de Octubre (imas12), Madrid, Spain., Luczkowiak J; Instituto de Investigación Sanitaria Hospital 12 de Octubre (imas12), Madrid, Spain., Labiod N; Instituto de Investigación Sanitaria Hospital 12 de Octubre (imas12), Madrid, Spain., Folgueira MD; Instituto de Investigación Sanitaria Hospital 12 de Octubre (imas12), Madrid, Spain.; Department of Microbiology, Hospital Universitario 12 de Octubre, Madrid, Spain., Delgado R; Instituto de Investigación Sanitaria Hospital 12 de Octubre (imas12), Madrid, Spain.; Centro de Investigación Biomédica en Red (CIBER) de Enfermedades Infecciosas (CIBERINFEC - Instituto de Salud Carlos III), Madrid, Spain.; Department of Microbiology, Hospital Universitario 12 de Octubre, Madrid, Spain.; Department of Medicine, Medical School, Universidad Complutense de Madrid, Madrid, Spain., Paz-Artal E; Instituto de Investigación Sanitaria Hospital 12 de Octubre (imas12), Madrid, Spain.; Department of Immunology, Hospital Universitario 12 de Octubre, Madrid, Spain.; Centro de Investigación Biomédica en Red (CIBER) de Enfermedades Infecciosas (CIBERINFEC - Instituto de Salud Carlos III), Madrid, Spain.; Department of Immunology, Ophthalmology and ENT, Medical School, Universidad Complutense de Madrid, Madrid, Spain.
Source: Frontiers in immunology [Front Immunol] 2022 Aug 17; Vol. 13, pp. 981350. Date of Electronic Publication: 2022 Aug 17 (Print Publication: 2022).
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Links:
  – Type: pdflink
Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 36059485
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Cellular and humoral immune responses and breakthrough infections after three SARS-CoV-2 mRNA vaccine doses.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Almendro-Vázquez+P%22">Almendro-Vázquez P</searchLink>; Instituto de Investigación Sanitaria Hospital 12 de Octubre (imas12), Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Chivite-Lacaba+M%22">Chivite-Lacaba M</searchLink>; Instituto de Investigación Sanitaria Hospital 12 de Octubre (imas12), Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Utrero-Rico+A%22">Utrero-Rico A</searchLink>; Instituto de Investigación Sanitaria Hospital 12 de Octubre (imas12), Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22González-Cuadrado+C%22">González-Cuadrado C</searchLink>; Instituto de Investigación Sanitaria Hospital 12 de Octubre (imas12), Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Laguna-Goya+R%22">Laguna-Goya R</searchLink>; Instituto de Investigación Sanitaria Hospital 12 de Octubre (imas12), Madrid, Spain.; Department of Immunology, Hospital Universitario 12 de Octubre, Madrid, Spain.; Centro de Investigación Biomédica en Red (CIBER) de Enfermedades Infecciosas (CIBERINFEC - Instituto de Salud Carlos III), Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Moreno-Batanero+M%22">Moreno-Batanero M</searchLink>; Instituto de Investigación Sanitaria Hospital 12 de Octubre (imas12), Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Sánchez-Paz+L%22">Sánchez-Paz L</searchLink>; Instituto de Investigación Sanitaria Hospital 12 de Octubre (imas12), Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Luczkowiak+J%22">Luczkowiak J</searchLink>; Instituto de Investigación Sanitaria Hospital 12 de Octubre (imas12), Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Labiod+N%22">Labiod N</searchLink>; Instituto de Investigación Sanitaria Hospital 12 de Octubre (imas12), Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Folgueira+MD%22">Folgueira MD</searchLink>; Instituto de Investigación Sanitaria Hospital 12 de Octubre (imas12), Madrid, Spain.; Department of Microbiology, Hospital Universitario 12 de Octubre, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Delgado+R%22">Delgado R</searchLink>; Instituto de Investigación Sanitaria Hospital 12 de Octubre (imas12), Madrid, Spain.; Centro de Investigación Biomédica en Red (CIBER) de Enfermedades Infecciosas (CIBERINFEC - Instituto de Salud Carlos III), Madrid, Spain.; Department of Microbiology, Hospital Universitario 12 de Octubre, Madrid, Spain.; Department of Medicine, Medical School, Universidad Complutense de Madrid, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Paz-Artal+E%22">Paz-Artal E</searchLink>; Instituto de Investigación Sanitaria Hospital 12 de Octubre (imas12), Madrid, Spain.; Department of Immunology, Hospital Universitario 12 de Octubre, Madrid, Spain.; Centro de Investigación Biomédica en Red (CIBER) de Enfermedades Infecciosas (CIBERINFEC - Instituto de Salud Carlos III), Madrid, Spain.; Department of Immunology, Ophthalmology and ENT, Medical School, Universidad Complutense de Madrid, Madrid, Spain.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101560960%22">Frontiers in immunology</searchLink> [Front Immunol] 2022 Aug 17; Vol. 13, pp. 981350. <i>Date of Electronic Publication: </i>2022 Aug 17 (<i>Print Publication: </i>2022).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Frontiers+Research+Foundation]%22">Frontiers Research Foundation] </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101560960 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Internet <i>ISSN: </i>1664-3224 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2216643224%22">16643224 </searchLink><i>NLM ISO Abbreviation: </i>Front Immunol <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=36059485
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.3389/fimmu.2022.981350
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 981350
    Titles:
      – TitleFull: Cellular and humoral immune responses and breakthrough infections after three SARS-CoV-2 mRNA vaccine doses.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Almendro-Vázquez P
      – PersonEntity:
          Name:
            NameFull: Chivite-Lacaba M
      – PersonEntity:
          Name:
            NameFull: Utrero-Rico A
      – PersonEntity:
          Name:
            NameFull: González-Cuadrado C
      – PersonEntity:
          Name:
            NameFull: Laguna-Goya R
      – PersonEntity:
          Name:
            NameFull: Moreno-Batanero M
      – PersonEntity:
          Name:
            NameFull: Sánchez-Paz L
      – PersonEntity:
          Name:
            NameFull: Luczkowiak J
      – PersonEntity:
          Name:
            NameFull: Labiod N
      – PersonEntity:
          Name:
            NameFull: Folgueira MD
      – PersonEntity:
          Name:
            NameFull: Delgado R
      – PersonEntity:
          Name:
            NameFull: Paz-Artal E
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 17
              M: 08
              Text: 2022 Aug 17
              Type: published
              Y: 2022
          Identifiers:
            – Type: issn-electronic
              Value: 1664-3224
          Numbering:
            – Type: volume
              Value: 13
          Titles:
            – TitleFull: Frontiers in immunology
              Type: main
ResultId 1